Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Revenue by Segment

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Pharmaceuticals Business		50.64B	46.90B	45.10B	43.46B	48.71B
Pharmaceuticals Business Growth		7.99%	3.98%	3.77%	-10.78%	8.27%
Total		50.64B	46.90B	45.10B	43.46B	48.71B
Total Growth		7.99%	3.98%	3.77%	-10.78%	8.27%

Revenue by Geography

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Japan		50.64B	46.90B	45.10B	43.46B	48.71B
Japan Growth		7.99%	3.98%	3.77%	-10.78%	8.27%
Total		50.64B	46.90B	45.10B	43.46B	48.71B
Total Growth		7.99%	3.98%	3.77%	-10.78%	8.27%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error